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Abstract
Previously, known actions of vitamin D were confined to skeletal health, but accumu‐
lating evidence has consistently suggested that vitamin D has pleomorphic roles in
overall human physiology. Hence, no other micronutrient deficiency in the modern
times has gained as much global attention as vitamin D deficiency. In this chapter, the
author reinforces what is already known in vitamin D and highlights several impor‐
tant findings in vitamin D research, with a special focus on one of the most vitamin D-
deficient regions in the world, the Middle East, and Saudi Arabia, in particular.
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1. Vitamin D physiology
Vitamin D plays an essential role in the regulation of calcium and phosphorus absorption and
metabolism for bone health. Nevertheless, the influence of vitamin D is more than just miner‐
al and skeletal homeostasis. The existence of vitamin D receptors (VDR) in several tissues and
organs  implies  that  vitamin  D  physiology  encompasses  beyond  bone  maintenance  [1].
Furthermore, the enzyme responsible for the conversion of 25[OH]D to its biologically active
form [Vitamin D (1,  25[OH]2D)] has been recognized in several  other tissues aside from
kidneys with evidence growing that extra renal synthesis of 1,  23[OH]2D may be just as
important in regulating the cell growth of cellular differentiation via paracrine or autocrine
regulatory mechanisms [2–4]. Figure 1 shows the schematic overview of vitamin D metabo‐
lism that starts in the liver, where vitamin D is hydroxylated to 25(OH)D, the main circulating
vitamin D metabolite used for vitamin D deficiency diagnosis [5]. Further hydroxylation of
25(OH)D to 1, 25(OH)D is catalyzed by 1α-hydroxylase which is expressed in multiple tissues
and binds to vitamin D receptors that in turn regulates various genes [5].
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Figure 1. Vitamin D metabolism overview (figure reprinted from Pilz et al. [5]).
Vitamin D’s etymology was obtained in the early part of the twentieth century after the
discovery of the antirachitic effect of cod liver oil [6]. Then, the unidentified vitamin in cod
liver oil was labeled as “D,” similar to vitamins A, B, and C, which have been already identified.
Synthesis of vitamin D from the skin provides most of the vitamin to the body (80–100%) and
with adequate sunlight exposure, dietary vitamin may be unnecessary. However, time spent
outdoors or the amount of incidental sun exposure on a regular basis, latitude, age, and skin
color influence the cutaneous production of vitamin D and therefore affect vitamin D status.
Foods rich in vitamin D include high-fat content fish (sardines, salmon, herring, and macker‐
el) that are meager and costly, since the study site is situated far from the coast, meat and egg,
and fortified milk, juice and margarine. Even in some countries where certain foods are
fortified with vitamin D, dietary intake of vitamin D is usually insufficient to maintain
adequate levels of 25-hydroxyvitamin D [7]. Currently, there are three treatment modalities
for vitamin D deficiency: sunlight, artificial ultraviolet B (UVB) radiation, and vitamin D
supplementation [7]. Ideal 25-hydroxyvitamin D [25(OH)D] levels continue to be debated in
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scientific circles and the definition of vitamin D deficiency changes almost yearly and ranges
become higher than previously thought. As of this writing, the most commonly accepted
definition of vitamin D deficiency is the one endorsed by the US Endocrine Society, that is,
circulating serum 25(OH)D levels <50 nmol/l (<20 ng/ml) [8].
2. Vitamin D deficiency prevalence
Globally, vitamin D deficiency is widespread and is considered as an epidemic [9]. In a
systematic literature review done by Hilger et al. in 44 countries involving more than 168,000
participants, 37.3% of the studies reported mean values <50 nmol/l, with the highest values
reported in. Furthermore, it was only in the Asia/Pacific and Middle East/African regions
where they observed age-related differences [10]. The recent study of Haq et al. also meas‐
ured vitamin D deficiency prevalence in a single laboratory in United Arab Emirates, and this
time involved 60,979 patients coming from 136 countries and revealed severe vitamin
deficiency (25(OH)D <25 nmol/l) in 23% of the subjects tested and another 37% falling under
mild deficiency (25(OH)D <50 nmol). This study is unique among other large-scale epidemio‐
logic studies since it involved several nationalities in one setting and using only one labora‐
tory, minimizing the need to adjust for known vitamin D cofactors such as geographical
location and variability between measurements [11]. The Middle East and North African
(MENA) region in general has a very high prevalence of vitamin D deficiency and is most
prominent in women of varying ages [12]. The Kingdom of Saudi Arabia (KSA), being part of
the MENA region, is not spared from vitamin D deficiency, despite the sunlight-rich environ‐
ment.
Sedrani [12] was the first to document vitamin D deficiency in KSA, and this was observed
among apparently healthy student males of King Saud University, Riyadh, KSA. Since then
and in the same year [12], other studies using different healthy subpopulations have emerged,
mostly women of child-bearing age [13–16]. In all studies, henceforth, vitamin D deficiency
ranged from one out of five Saudis, to almost 100%. Consequently, at this time, rapid indus‐
trialization was taking place at KSA. Environmental risk factors in lifestyle such as daytime
sleep and night time activities, work environments, which are sedentary and extreme weather
conditions, may have been contributory [17]. Certain groups, such as the elderly, dark skinned,
and/or veiled women and their children, are at particular risk of hypovitaminosis D [7, 18].
But more importantly, urbanization and tremendous socioeconomic growth has resulted in
profound changes in the way of life during the last three decades, resulting in an increased
and sustained incidence of obesity and type-2 diabetes mellitus [19], diseases known to elicit
depressed circulating levels of vitamin D. As time passed, and with advancing technology and
faster dissemination of information, epidemiologic studies on vitamin D deficiency across KSA
has emerged. Through the initiatives of HRM, King Abdullah bin Abdulaziz Al-Saud, and the
thrust for a knowledge-based economy, the research industry in KSA exponentially flourish‐
ed and with it, several large scale studies paved way for exposing the worsening vitamin D
deficiency in KSA [20, 21]. Furthermore, debilitating diseases associated with vitamin D
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deficiency have started to emerge and become more prominent, including osteoporosis [22],
type-2 diabetes mellitus [23, 24], and systemic lupus erythematosus [25] to name a few.
3. Diseases associated with vitamin D deficiency
Vitamin D deficiency has been consistently associated with hypertension, diabetes mellitus,
cardiovascular disease, stroke, multiple sclerosis, inflammatory bowel disease, osteoporosis,
periodontal disease, macular degeneration, mental illness, propensity to fall, and chronic pain
and various cancers [26]. Most tissues have not only vitamin D receptors, but also hydroxy‐
lase enzyme that is required to convert 25(OH)D to the active form, 1α,25-dihydroxyvitamin
D3 [27]. Therefore, vitamin D can affect tissues that are not involved in calcium homeostasis
and bone metabolism. Almost all tissues in the body possess vitamin D receptors including
brain, heart skeletal muscle, smooth muscle cells, pancreas, activated T and B lymphocytes,
and monocytes [28].
The major diseases associated with vitamin D deficiency in KSA are listed in Table 1. Among
these, the most widely documented include vitamin D deficiency rickets among Saudi children
and type-1 diabetes mellitus and osteoporosis in adults. It is expected that with the increasing
elderly Saudi population, the prevalence of chronic noncommunicable diseases, including
osteoporosis in KSA, will increase if not remain steady, and uncorrected vitamin D deficiency
being a risk factor for these diseases will play a major role in the progression of these diseases.
It is worth to note that among these diseases, the emergence of increasing incidence of
fibromyalgia or chronic muscle pain is mostly experienced by Saudi women, which showed
significant improvement after treatment of high-dose vitamin D [52, 53], and reversal of
metabolic syndrome manifestations among Saudi adults by mere increased sun exposure [54].
Several intervention studies are further required for the rest of the nonskeletal diseases where
vitamin D is involved to determine whether vitamin D status correction will provide major
beneficial effect.
Diseases References
Chronic low back pain [29]
Fibromyalgia [30, 31]
Hyperparathyroidism [32, 33]
Obesity and the metabolic syndrome [21, 23, 24, 34, 35]
Osteoporosis/osteopenia/osteomalacia [20–22, 36–44]
Sickle cell disease [45, 46]
Systemic lupus erythematosus [25]
Type-1 diabetes mellitus [47–49]
Type-2 diabetes mellitus [39, 50, 51]
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Table 1. List of major diseases associated with vitamin D deficiency in Saudi Arabia.
4. Treatment
The two commonly available forms of vitamin D supplements are ergocalciferol (vitamin D2)
and cholecaleiferol (vitamin D3). Some, but not all, studies suggest that vitamin D3 increase
serum 25[OH]D more efficiently than does vitamin D2 [55–57]. The best indicator of vitamin
D status is 25-hydroxyvitamin D because it is the major circulating form of vitamin D; it reflects
cutaneous and dietary intake [58]. A nonfasting sample taken at any time of the day is suitable
for the measurement of 25-hydroxyvitamin D status. Although calcitriol 1,25 dihydroxycho‐
lecalciferol is the active form of vitamin D, it is not an appropriate indicator of vitamin D status.
It is usually normal or even elevated in patients with vitamin D deficiency. Although reliable
and consistent evaluation of serum 25[OH]D level remains an issue, reliable laboratories
currently exist, and efforts are in progress to improve and standardize assays to enhance
accuracy and reproducibility at other laboratories.
Adults with 25 OHD 50–75 nmol/L require treatment with 800 to 1000 IU of vitamin D3 daily.
This intake was hypothesized to increase the vitamin D status to 7 nmol/L over a three-month
period, but still, many individuals might require higher doses. In malabsorptive states, oral
dosing and treatment duration depend on the individual patient’s vitamin D absorptive
capacity. Mega doses of vitamin D (10,000 to 50,000 IU daily) may be essential for
postgastrectomy patients or patients with malabsorption. In cases where such patients remain
deficient/insufficient despite such doses, they should be treated with hydroxylated vitamin D
metabolites (since they are more readily absorbed) or with sun or sun camp exposure. All
patients should maintain a daily calcium intake of at least 1000 mg (for ages 31 to 50 years)
to 1200 mg (>51 years old) per day [59].
Since vitamin D is a fat-soluble vitamin, there are concerns about toxicity from excessive
supplementation. Widespread fortification of food and drink from the 1930s to 1950s in the
United States and Europe led to reported cases of toxicity. Increased levels of vitamin also raise
calcium levels. Most of the symptoms of vitamin D toxicity are secondary to hypercalcemia.
Early symptoms include, but are not limited to, gastrointestinal disorders like anorexia,
diarrhea, constipation, nausea, and vomiting. Other reported symptoms include bone pain,
drowsiness, continuous headaches, irregular heartbeat, loss of appetite, muscle, and joint pain
are other symptoms that are likely to appear within a few days or weeks; frequent urination,
especially at night, excessive thirst, weakness, nervousness and itching, and kidney stones [60].
5. Conclusion
This chapter provides a glimpse on the essential knowledge about this micronutrient vitamin
D, as it is one of the most clinically important nutritional deficiencies. It is by no means
comprehensive but nevertheless equips the reader with vital information on vitamin D with
special attention in the Middle East and Saudi Arabia.
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